Diffuse midline glioma (DMG) is a highly lethal childhood cancer of the central nervous system, particularly affecting the brainstem and thalamus, and is associated with a specific mutation in the H3 histone gene (H3K27M). With limited therapeutic options available, median survival is only 11-13 months. Research indicates that DMGs likely originate from oligodendroglial precursor cells, which are influenced by neuronal activity. This interplay includes GABAergic and glutamatergic neuronal signaling, crucial for glioma cell proliferation, which highlights the urgent need for deeper insights into electrochemical mechanisms in DMG treatment strategies.
DMG, a lethal childhood CNS cancer, features H3K27M mutations and shows aggressive growth due to neuronal activity's influence on glioma proliferation.
Neuronal-derived signals play a pivotal role in the progression of DMG by fostering oligodendroglial precursor cell activity, critical for glioma development.
Collection
[
|
...
]